NIH-funded research R21 grant

Understanding how a parasite causes sleeping sickness through cell signaling

Official title: Flagellar cAMP signaling in Trypanosoma brucei

Funded at University of California Los Angeles · NIH-10993198 · Data updated 2026-11-12

This study is looking at how the sleeping sickness parasite, Trypanosoma brucei, senses its surroundings and moves around, which could help us find new ways to treat the disease.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startDecember 1, 2023
Project endOctober 31, 2025
Funding year2025
Award (this year)$186,070
NIH project number5R21AI178355-02
Project IDNIH-10993198 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living in sub-Saharan Africa who are at risk of or affected by African sleeping sickness.

Less likely to help

Patients who do not reside in sub-Saharan Africa or those who are not affected by African sleeping sickness may not benefit from this research.

What this research studies

This research investigates the signaling pathways in the Trypanosoma brucei parasite, which is responsible for sleeping sickness. By studying how this parasite senses and responds to its environment, the research aims to uncover critical mechanisms that allow it to survive and spread. The approach involves genetic manipulation of the parasite to explore its flagellum, a structure essential for its movement and communication. This could lead to new insights into potential treatments for the disease.

Why it matters

Potential benefit: If successful, this research could lead to the development of new treatments for African sleeping sickness.

How similar studies have gone: Other research has shown success in understanding similar signaling pathways in related parasites, indicating potential for breakthroughs in treatment.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Hill, Kent L — University of California Los Angeles
  • Study coordinator: Hill, Kent L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.